Total | Alive or unrelated death | Tumour-related death | P value | |
---|---|---|---|---|
Sex | ||||
Female | 74 (44.0%) | 11 (42.3%) | 63 (44.4%) | 0.846 |
Male | 94 (56.0%) | 15 (57.7%) | 79 (55.6%) | |
Race | ||||
White | 113 (67.3%) | 17 (65.4%) | 96 (67.6%) | 0.960 |
Black | 32 (19.0%) | 5 (19.2%) | 27 (19.0%) | |
Other | 23 (13.7%) | 4 (15.4%) | 19 (13.4%) | |
Age at diagnosis | ||||
< 45 | 87 (51.8%) | 18 (69.2%) | 69 (48.6%) | 0.053 |
≥ 45 | 81 (48.2%) | 8 (30.8%) | 73 (51.4%) | |
Marital status | ||||
Married | 93 (55.4%) | 14 (53.8%) | 79 (55.6%) | 0.426 |
Single | 41 (24.4%) | 8 (30.8%) | 33 (23.2%) | |
Other | 27 (16.1%) | 2 (7.7%) | 25 (17.6%) | |
Unknown | 7 (4.2%) | 2 (7.7%) | 5 (3.5%) | |
Histological grade | ||||
I | 1 (0.6%) | 0 (0.0%) | 1 (0.7%) | 0.578 |
II | 5 (3.0%) | 2 (7.7% | 3 (2.1% | |
III | 26 (15.5%) | 3 (11.5%) | 23 (16.2%) | |
IV | 29 (17.3% | 5 (19.2% | 24 (16.9% | |
Unknown | 107 (63.7%) | 16 (61.5%) | 91 (64.1%) | |
AJCC TNM stage | ||||
I | 1 (0.6%) | 11 (42.3%) | 2 (1.4%) | 0.064 |
II | 9 (5.4%) | 0 (0.0%) | 8 (5.6%) | |
III | 10 (6.0%) | 4 (15.4%) | 6 (4.2%) | |
IV | 52 (31.0%) | 0 (0.0%) | 41 (28.9%) | |
Unstaged | 96 (57.1%) | 11 (42.3%) | 85 (59.9%) | |
Tumour size | ||||
< 3 cm | 9 (5.4%) | 3 (11.5%) | 6 (4.2%) | 0.104 |
3–5 cm | 32 (19.0%) | 6 (23.1%) | 26 (18.3%) | |
> 5 cm | 63 (37.5%) | 11 (42.3%) | 52 (36.6%) | |
Unknown | 64 (38.1%) | 6 (23.1%) | 58 (40.8%) | |
LN metastases | ||||
Yes | 14 (8.3%) | 3 (11.5%) | 11 (7.7%) | 0.135 |
No | 72 (42.9%) | 15 (57.7%) | 57 (40.1%) | |
Unknown | 82 (48.8%) | 8 (30.8%) | 74 (52.1%) | |
Distant metastases | ||||
Yes | 49 (29.2%) | 11 (42.3%) | 38 (26.8%) | 0.088 |
No | 41 (24.4%) | 8 (30.8%) | 33 (23.2%) | |
Unknown | 78 (46.4%) | 7 (26.9%) | 71 (50.0%) | |
Radiation | ||||
Yes | 44 (26.2%) | 11 (42.3%) | 33 (23.2%) | 0.004 |
No/unknown | 124 (73.8%) | 15 (57.7%) | 109 (76.8%) | |
Surgery | ||||
Yes | 80 (47.6%) | 14 (53.8%) | 66 (46.5%) | 0.489 |
No/unknown | 88 (52.4%) | 12 (46.2%) | 76 (53.5%) | |
Summary stage | ||||
Localized | 33 (19.6%) | 6 (23.1%) | 27 (19.0%) | 0.248 |
Regional | 44 (26.2%) | 6 (23.1%) | 38 (26.8%) | |
Distant | 87 (51.8%) | 12 (46.2%) | 75 (52.8%) | |
Unstaged | 4 (2.4%) | 2 (7.7%) | 2 (1.4%) | |
Year of diagnosis | ||||
1973–1988 | 21 (12.5%) | 1 (3.8%) | 20 (14.1%) | 0.045 |
1989–2002 | 48 (28.6%) | 4 (15.4%) | 44 (31.0%) | |
2003–2013 | 99 (58.9%) | 21 (80.8%) | 78 (54.9%) | |
Sequence number | ||||
1st | 158 (94.0%) | 25 (96.2%) | 133 (93.7%) | 0.622 |
2nd | 10 (6.0%) | 1 (3.8%) | 9 (6.3%) |